Amicus Webinar
The webinar “Flu Vaccination: Privilege of the Older or…?” organized by Amicus, a Swixx Biopharma company, will explore the importance and accessibility of flu vaccines, particularly for older adults. This event aims to highlight the crucial role that influenza vaccination plays in protecting vulnerable populations, including the elderly, from severe illness and complications. The discussion will cover topics such as vaccine efficacy, the benefits of annual flu shots, and strategies to improve vaccination rates among older individuals. Expert speakers from the medical and pharmaceutical fields will share insights and data on the current flu season, addressing common misconceptions and barriers to vaccination. The webinar is designed for healthcare professionals, public health officials, and anyone interested in public health initiatives. It seeks to promote a broader understanding of the necessity of flu vaccination beyond age-related considerations, emphasizing it as a vital public health measure.
Planning and coordinating the event’s agenda, securing expert speakers, managing the technical aspects of the webinar platform. Promotional activities, creating marketing materials and outreach to target audiences. Management of participant registration, providing technical support during the event, ensuring smooth execution. Post-event tasks include collecting feedback, distributing recorded sessions, and analyzing engagement metrics.
Swixx BioPharma was created to replace biopharma, OTC and medical device multinationals’ subsidiaries in those countries, or therapeutic areas, that our partners choose not to enter, or to exit. Over the last ten years, we have swiftly evolved into one of the largest, most professional and reliable partners in the countries of Central & Eastern Europe, Russia/Eurasia and Greece for international healthcare companies.
And we are continuing to grow. In September 2023, we opened for new opportunities in the Middle East. In May 2024, Swixx expanded to Latin America with a strategic acquisition and combination with Laboratorios Biopas SA. Through Biopas’ comprehensive Latam continental coverage, Swixx is now able to provide a compelling offering covering Central and Eastern Europe, CIS/Eurasia, MENA and Latin America.
At Swixx, we believe that every human being deserves access to the latest, evidence-based medical innovation. We are proud to have been selected by many of the world’s finest healthcare companies to bring their products to patients. We don’t have our own portfolio (or R&D, or production) which means that we can devote 100% of our care and attention to launching our partners’ highly innovative medicines and working on improving diagnoses. We share the values of our partners in healthcare and work to the same ethical and quality standards.
